statistiche ricercatore

PAROLARO, DANIELA

Distribuzione geografica

Continente	#
NA - Nord America	12.702
EU - Europa	7.763
AS - Asia	1.662
SA - Sud America	19
Continente sconosciuto - Info sul continente non disponibili	15
OC - Oceania	7
AF - Africa	4
Totale	22.172

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	12.661
IT - Italia	4.063
UA - Ucraina	1.450
SE - Svezia	760
TR - Turchia	613
VN - Vietnam	421
CN - Cina	387
FI - Finlandia	367
IE - Irlanda	356
DE - Germania	320
GB - Regno Unito	214
SG - Singapore	162
FR - Francia	100
CA - Canada	38
JP - Giappone	34
BE - Belgio	30
CZ - Repubblica Ceca	24
NL - Olanda	17
IN - India	16
EU - Europa	15
RU - Federazione Russa	14
BR - Brasile	8
ES - Italia	7
BG - Bulgaria	6
AU - Australia	5
CL - Cile	5
DK - Danimarca	5
PK - Pakistan	5
PT - Portogallo	5
CH - Svizzera	4
AE - Emirati Arabi Uniti	3
CO - Colombia	3
HK - Hong Kong	3
HU - Ungheria	3
KR - Corea	3
MY - Malesia	3
AR - Argentina	2
GR - Grecia	2
IL - Israele	2
LT - Lituania	2
LU - Lussemburgo	2
MD - Moldavia	2
MX - Messico	2
NG - Nigeria	2
NZ - Nuova Zelanda	2
RO - Romania	2
AL - Albania	1
AT - Austria	1
BT - Bhutan	1
EC - Ecuador	1
EE - Estonia	1
EG - Egitto	1
ID - Indonesia	1
IR - Iran	1
JO - Giordania	1
KZ - Kazakistan	1
LA - Repubblica Popolare Democratica del Laos	1
LI - Liechtenstein	1
MA - Marocco	1
MM - Myanmar	1
MN - Mongolia	1
MT - Malta	1
NO - Norvegia	1
PA - Panama	1
PH - Filippine	1
PL - Polonia	1
SK - Slovacchia (Repubblica Slovacca)	1
TW - Taiwan	1
Totale	22.172

Salva come PNG Salva come JPEG

Città	#
Milan	2.844
Fairfield	1.834
Woodbridge	1.128
Jacksonville	1.099
Chandler	1.089
Ashburn	986
Houston	828
Seattle	793
Wilmington	728
Ann Arbor	659
Cambridge	607
Dearborn	393
Princeton	380
Dublin	355
Izmir	352
Nyköping	349
Rome	231
Boardman	224
Dong Ket	218
Como	192
San Mateo	161
Singapore	147
New York	100
San Diego	88
Chicago	81
Beijing	70
Ogden	61
Washington	59
Hefei	48
Santa Clara	45
Kunming	42
Norwalk	38
London	34
Nanjing	34
Tokyo	31
Brussels	30
Toronto	29
Los Angeles	27
Munich	26
Helsinki	23
Ponte Lambro	23
Brno	22
Nanchang	19
Verona	19
Guangzhou	18
Mcallen	18
Redwood City	18
Dallas	17
Kocaeli	17
Berlin	16
Düsseldorf	16
Fuzhou	14
Jinan	14
Falls Church	13
Carbonara Al Ticino	12
Edinburgh	12
Cagliari	10
Frankfurt am Main	9
Ottawa	8
Redmond	8
Shenyang	8
Varese	8
Benevento	7
Bologna	7
Chengdu	7
Kilburn	7
Naples	7
Wuhan	7
Amritsar	6
Ankara	6
Istanbul	6
Pune	6
Sofia	6
Zhengzhou	6
Auburn Hills	5
Chongqing	5
Lisbon	5
Phoenix	5
Shanghai	5
Siena	5
Wandsworth	5
Amsterdam	4
Bari	4
Bollate	4
Cairate	4
Chiswick	4
Copenhagen	4
Hebei	4
Hounslow	4
Islamabad	4
Madrid	4
Napoli	4
Prescot	4
San Giuliano Milanese	4
Stuttgart	4
Villanovafranca	4
Borgomanero	3
Budapest	3
Changsha	3
Dubai	3
Totale	16.967

Salva come PNG Salva come JPEG

Nome	#
Adolescent exposure to THC in female rats disrupts developmental changes in the prefrontal cortex	246
Cannabidiol, a Non-Psychoactive Cannabinoid Compound, Inhibits Proliferation and Invasion in U87-MG and T98G Glioma Cells through a Multitarget Effect	225
Alterations of prefrontal cortex GABAergic transmission in the complex psychotic-like phenotype induced by adolescent delta-9-tetrahydrocannabinol exposure in rats	217
Bidirectional regulation of mu-opioid and CB1-cannabinoid receptor in rats self-administering heroin or WIN 55,212-2	205
The Depressive Phenotype Induced in Adult Female Rats by Adolescent Exposure to THC is Associated with Cognitive Impairment and Altered Neuroplasticity in the Prefrontal Cortex	199
Assay of GTPγS binding in autoradiography	197
Binding of Δ9-tetrahydrocannabinol and diazepam to human serum albumin	196
CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour	194
Adolescent THC exposure in female rats leads to cognitive deficits through a mechanism involving chromatin modifications in the prefrontal cortex	193
Long lasting consequences of cannabis exposure in adolescence.	190
Cannabis abuse in adolescence and the risk of psychosis: A brief review of the preclinical evidence.	190
Cannabidivarin completely rescues cognitive deficits and delays neurological and motor defects in male Mecp2 mutant mice	190
Transcriptomic and Proteomic Analyses of Mouse Cerebellum Reveals Alterations in RasGRF1 Expression Following In Vivo Chronic Treatment with Delta 9-Tetrahydrocannabinol.	189
Adolescent exposure to cannabis as a risk factor for psychiatric disorders	189
5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid.	186
New vistas on cannabis use disorder	186
Cannabinoid CB1 receptor antagonism prevents neurochemical and behavioural deficits induced by chronic phencyclidine	184
Long-term hippocampal glutamate synapse and astrocyte dysfunctions underlying the altered phenotype induced by adolescent THC treatment in male rats.	184
Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex	183
A molecular basis of analgesic tolerance to cannabinoids	181
Cannabidiol inhibits human glioma cell migration through a cannabinoid receptor-independent mechanism	176
Cannabinoids and opioids share cAMP pathway in rat splenocytes	172
MeCP2 related studies benefit from the use of CD1 as genetic background	172
Endocannabinoids and Mental Disorders.	169
The anabolic steroid nandrolone alters cannabinoid self-administration and brain CB1 receptor density and function	162
Role of endocannabinoids in regulating drug dependence	161
Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat	160
Expression and function of the endocannabinoid system in glial cells.	158
Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine	157
Chronic treatment with polychlorinated biphenyls (PCB) during pregnancy and lactation in the rat Part 1: Effects on somatic growth, growth hormone-axis activity and bone mass in the offspring	157
Cannabinoids and Drugs of abuse	156
Neurobiological alterations at adult age triggered by adolescent exposure to cannabinoids.	155
Modulation of rat brain cannabinoid receptors after chronic morphine treatment	154
Ruolo della via Ras-ERK nella dipendenza ai cannabinoidi	154
The endocannabinoid system and schizophrenia: integration of evidence.	154
CANNABIDIOL/PHYTOCANNABINOIDS: A NEW OPPORTUNITY FOR SCHIZOPHRENIA TREATMENT?	154
Adult Cellular Neuroadaptations Induced by Adolescent THC Exposure in Female Rats Are Rescued by Enhancing Anandamide Signaling	154
Chronic URB597 treatment at adulthood reverted most depressive-like symptoms induced by adolescent exposure to THC in female rats.	151
Mice heterozygous for the oxytocin receptor gene (Oxtr(+/-) ) show impaired social behaviour but not increased aggression or cognitive inflexibility: evidence of a selective haploinsufficiency gene effect.	151
Ruolo emergente del sistema degli endocannabinoidi nelle malattie neuropsichiatriche	151
Comparative analysis of molecular strategies attenuating positional effects in lentiviral vectors carrying multiple genes	150
Sex-dependent vulnerability to cannabis abuse in adolescence	148
Molecular and cellular basis of cannabinoid and opioid interactions	147
Remote memories are enhanced by COMT activity through dysregulation of the endocannabinoid system in the prefrontal cortex	147
Changes in hippocampal morphology and neuroplasticity induced by adolescent THC treatment are associated with cognitive impairment in adulthood	144
AM630 behaves as a protean ligand at the human cannabinoid CB(2) receptor.	144
SK channel modulation rescues striatal plasticity and control over habit in cannabinoid tolerance.	144
Cellular mechanisms underlying the interaction between cannabinoid and opioid system	142
Gender-dependent behavioral and biochemical effects of adolescent delta-9-tetrahydrocannabinol in adult maternally deprived rats.	141
Endocannabinoids and Drug Dependence	140
Involvement of the endocannabinoid system in phencyclidine-induced cognitive deficits modelling schizophrenia.	139
Cannabidivarin Treatment Ameliorates Autism-Like Behaviors and Restores Hippocampal Endocannabinoid System and Glia Alterations Induced by Prenatal Valproic Acid Exposure in Rats	139
Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems	137
Endocannabinoids in the immune system and cancer	136
The psychoactive ingredient of marijuana induces behavioural sensitization	135
Differential diurnal variations of anandamide and 2-arachidonoyl-glycerol levels in rat brain	135
In vivo characterization of the specific cannabinoid receptor antagonist, SR 141716A: behavioral and cellular responses after acute and chronic treatments	134
Oral anti-inflammatory activity of cannabidiol, a non-psychoactive constituent of cannabis, in acute carrageenan-induced inflammation in the rat paw	134
Changes in the cannabinoid receptor binding, G protein coupling, and cyclic AMP cascade in the CNS of rats tolerant to and dependent on the synthetic cannabinoid compound CP55,940	133
Ras/ERK signalling in cannabinoid tolerance: from behaviour to cellular aspects	133
The endocannabinoid system and psychiatric disorders.	133
Cannabidiol inhibits angiogenesis by multiple mechanisms	133
Chronic treatment with the endocannabinoid anandamide increases cytochrome P450 metabolizing system in the rat	132
null	132
Cannabimimetic activity, binding, and degradation of stearoylethanolamide within the mouse central nervous system	131
Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brain	130
Binding studies of dermorphin and its L-form on rat brain opioid receptors.	129
Changes in the expression of G protein-coupled receptor kinases and beta-arrestins in mouse brain during cannabinoid tolerance - A role for Ras-ERK cascade	127
Long-lasting recovery of psychotic-like symptoms in isolation-reared rats after chronic but not acute treatment with the cannabinoid antagonist AM251.	127
The phytocannabinoid, delta-9-tetrahydrocannabivarin, can act through 5-HT1A receptors to produce antipsychotic effects	127
Presence and functional regulation of cannabinoid receptors in immune cells	126
Cholera toxin effects on body temperature changes induced by morphine.	126
Effect on intestinal transit of neurotensin administered intracerebroventricularly to rats.	126
Pharmacologic rescue of impaired cognitive flexibility, social deficits, increased aggression, and seizure susceptibility in oxytocin receptor null mice: a neurobehavioral model of autism.	124
A role of nitric oxide in WIN 55,212-2 tolerance in mice.	124
Cellular Mechanisms Underlying The Anxiolytic Effect Of Low Doses Of Peripheral D9-Tetrahydrocannabinol In Rats	123
Pertussis toxin inhibits the antinociceptive action of morphine in the rat..	123
Cannabinoids inhibit nitric oxide production in bone marrow derived feline macrophages	122
Sex-dependent changes in brain CB1R expression and functionality and immune CB2R expression as a consequence of maternal deprivation and adolescent cocaine exposure	122
Susceptibility to Psychiatric Diseases After Cannabis Abuse in Adolescence: Animal Models	122
Neurobiological mechanisms underlying cannabis-induced memory impairment	122
Cannabinoids as potential new therapy for the treatment of gliomas.	121
Presence of a reduced opioid response in interleukin-6 knock out mice	121
In vivo and in vitro treatment with the synthetic cannabinoid CP55, 940 decreases the in vitro migration of macrophages in the rat: involvement of both CB1 and CB2 receptors	120
The nonpsychoactive component of marijuana cannabidiol modulates chemotaxis and IL-10 and IL-12 production of murine macrophages both in vivo and in vitro.	120
Long-term consequences of URB597 administration during adolescence on cannabinoid CB1 receptor binding in brain areas.	120
Cannabinoids, immune system and cytokine network	119
Chronic cannabinoid, CP-55,940, administration alters biotransformation in the rat.	119
Estrogenic effect of procymidone through activation of MAPK in MCF-7 breast carcinoma cell line	117
Involvement of periaqueductal gray matter in intestinal effect of centrally administered morphine..	117
Lifelong imbalanced linoleic/alpha-linolenic acid intake impairs emotional and cognitive behavior in adult rats via changes in brain endocannabinoid system	117
The non-psychoactive cannabidiol triggers caspase activation and oxidative stress in human glioma cells	116
Intracerebral self-administration of the cannabinoid receptor agonist CP 55,940 in the rat: interaction with the opioid system	115
The Impact of Exposure to Cannabinoids in Adolescence: Insights from Animal Models	114
Further investigations on the antipropulsive effect of centrally administered histamine and its relation with morphine.	113
Changes in rat spleen cannabinoid receptors after chronic CP-55,940: an autoradiographic study.	113
Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors	112
Influence of pertussis toxin on thermic responses to morphine and neurotensin in rats..	112
Sexually dimorphic effects of cannabinoid compounds on emotion and cognition.	110
Cellular mechanisms of Delta(9)-tetrahydrocannabinol behavioural sensitization	109
Totale	14.770

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	76.115
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	76.115

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2019/2020	3.160	0	0	0	0	331	536	665	586	362	326	79	275
2020/2021	3.189	80	340	132	300	192	343	143	248	470	168	295	478
2021/2022	1.930	192	203	182	251	58	89	71	94	94	282	149	265
2022/2023	2.722	265	165	192	326	157	582	10	378	399	75	120	53
2023/2024	4.570	717	743	725	832	902	350	31	76	100	28	23	43
2024/2025	701	39	42	483	78	59	0	0	0	0	0	0	0
Totale													22.301